quinazolines has been researched along with Leukoencephalopathy Syndrome, Posterior in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, QS; Hennig, R; Kim, CA; Price-Hiller, J; Sawyer, MB; Spratlin, JL; Tankel, K | 1 |
1 other study(ies) available for quinazolines and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Male; Posterior Leukoencephalopathy Syndrome; Protein Kinase Inhibitors; Quinazolines; Rectal Neoplasms | 2014 |